Cardiovascular & Thoracic Surgery News 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Science Saturday: Researchers explore personalized approach to anti-obesity medications
Individualized medicine initiatives mainly focus on rare diseases or cancer. Little has been attempted to individualize treatment for noncommunicable chronic diseases such as obesity -- a chronic, relapsing disease, and a primary cause of Type 2 diabetes, fatty liver disease, cardiovascular disease and cancer. There are many obesity interventions, such as diets, devices, surgery and [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 1, 2021 Category: Databases & Libraries Source Type: news
Study finds similar long-term outcomes for mechanically-ventilated COVID-19 patients
(American Association for Thoracic Surgery) A new study, presented today at the AATS 101st Annual Meeting, found that severely ill COVID-19 patients treated with ECMO did not suffer worse long-term outcomes than other mechanically-ventilated patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 30, 2021 Category: International Medicine & Public Health Source Type: news
Roche launches new ways to use their cardiovascular tests empowering clinicians to improve diagnosis and treatment of millions of people
Basel, 28 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced a series of five new intended uses for two key cardiac biomarkers using the Elecsys ® technology: high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These gold standard biomarkers³ have proven to be successful in supporting cardiovascular disease management and can help clinicians diagnose heart attacks⁴ (cTnT-hs) and bett er manage heart failure⁵ (NT-proBNP). Roche ' s introduction of five new intended uses for these existing, globally accepted diagnostic solutions means more people could benef...
Source: Roche Investor Update - April 28, 2021 Category: Pharmaceuticals Source Type: news
Roche launches new ways to use their cardiovascular tests empowering clinicians to improve diagnosis and treatment of millions of people
Basel, 28 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced a series of five new intended uses for two key cardiac biomarkers using the Elecsys ® technology: high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These gold standard biomarkers³ have proven to be successful in supporting cardiovascular disease management and can help clinicians diagnose heart attacks⁴ (cTnT-hs) and bett er manage heart failure⁵ (NT-proBNP). Roche ' s introduction of five new intended uses for these existing, globally accepted diagnostic solutions means more people could benef...
Source: Roche Media News - April 28, 2021 Category: Pharmaceuticals Source Type: news
AATS 101st Annual Meeting tip sheet
(American Association for Thoracic Surgery) The American Association for Thoracic Surgery Annual Meeting is the oldest and largest cardiothoracic surgery meeting in North America. The 101st Annual Meeting will be held virtually April 30 - May 2, 2021 (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 28, 2021 Category: International Medicine & Public Health Source Type: news
Mayo Clinic Q & amp;A podcast: Reducing rejection by reversing order of heart-liver transplant
For heart-liver transplants, the liver and heart must come from the same donor, and some patients wait years to receive both organs. Also, antibodies from the donor can increase chances of the receiving patient rejecting the heart. But Dr. Sudhir Kushwaha, a Mayo Clinic cardiovascular transplant surgeon, says when a liver transplant is also involved, [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 27, 2021 Category: Databases & Libraries Source Type: news
Delaying cardiovascular surgeries due to COVID-19 has psychological effects on patients
(Michigan Medicine - University of Michigan) Postponing procedures during the pandemic sparked anxiety and fear among patients, with many concerned about dying of their conditions before getting surgery. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 19, 2021 Category: Infectious Diseases Source Type: news
Weight linked to risk of second cancer after breast cancer
Breast cancer survivors who are overweight have a higher risk of developin...Read more on AuntMinnie.comRelated Reading:
Thoracic CT shows promise for monitoring health of obese patients
CT-guided renal ablation is safe for treating cancer in obese patients
Black women with breast cancer show high comorbidity rates
Weight-loss surgery weakens teenagers' bones
Use CTA to evaluate obese COVID-19 patients for PE risk (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 14, 2021 Category: Radiology Source Type: news
COVID-19 Patient Receives Lung Transplant From Living Donors
TOKYO — Doctors in Japan announced Thursday they have successfully performed the world’s first transplant of lung tissue from living donors to a patient with severe lung damage from COVID-19.
The recipient, identified only as a woman from Japan’s western region of Kansai, is recovering after the nearly 11-hour operation on Wednesday, Kyoto University Hospital said in a statement. It said her husband and son, who donated parts of their lungs, are also in stable condition.
The university said it was the world’s first transplant of lung tissue from living donors to a person with COVID-19 lung damage. T...
Source: TIME: Health - April 9, 2021 Category: Consumer Health News Authors: MARI YAMAGUCHI / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news
AHA News: For Heart Patients, Bariatric Surgery May Lower Risk of Future Cardiovascular Problems
Title: AHA News: For Heart Patients, Bariatric Surgery May Lower Risk of Future Cardiovascular ProblemsCategory: Health NewsCreated: 4/5/2021 12:00:00 AMLast Editorial Review: 4/6/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - April 6, 2021 Category: Cardiology Source Type: news
AHA News: For Heart Patients, Bariatric Surgery May Lower Risk of Future Cardiovascular Problems
MONDAY, April 5, 2021 (American Heart Association News) -- Bariatric surgery can be a difficult decision for treating obesity, as patients and their doctors weigh the risks and side effects of the procedure against the benefits of the weight loss... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 5, 2021 Category: General Medicine Source Type: news
Mayo Clinic Q & amp;A podcast: Esophageal cancer is one of the deadliest cancers
Esophageal cancer occurs in the esophagus -- a long, hollow tube that runs from the throat to the stomach -- and can occur anywhere along the esophagus. Men are more likely to develop esophageal cancer than women. While treatable, esophageal cancer is rarely curable. "It's an uncommon cancer," says Dr. Shanda Blackmon, a Mayo Clinic general thoracic surgeon. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 5, 2021 Category: Databases & Libraries Source Type: news
Phase III Trial of Durvalumab for Mesothelioma Underway
The U.S. Food and Drug Administration will be closely watching the latest, international phase III clinical trial for unresectable pleural mesothelioma involving the immunotherapy drug durvalumab.
FDA approval may be coming soon.
“It looks very promising,” Dr. Arkadiusz Dudek, of Regions Hospital Cancer Care Center in St. Paul, Minnesota, told The Mesothelioma Center at Asbestos.com. “The hope is to have the regimen approved by the FDA as front-line therapy. There is a real need today for more options with mesothelioma.”
The goal of the randomized trial – officially known as DREAM3R – is to determine h...
Source: Asbestos and Mesothelioma News - April 1, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news
Thoracic Surgeon Raja Flores Enters NYC Mayor ’s Race
Thoracic surgeon and mesothelioma specialist Dr. Raja Flores wants to continue serving others, but in a new role as the next mayor of New York City.
“Yes, I’m serious about this. Very serious,” Flores told The Mesothelioma Center at Asbestos.com Tuesday after another 14-hour workday and an evening surgery at Mount Sinai. “I want to take care of this city that has taken such good care of me.”
Flores, the esteemed chairman of thoracic surgery at Mount Sinai Hospital, filed his official eligibility petition last week with the New York City Board of Elections.
He listed himself as an independent, joining mor...
Source: Asbestos and Mesothelioma News - March 25, 2021 Category: Environmental Health Authors: Amy Edel Source Type: news
Total Knee Replacement Cost-Effective, Even With Obesity and Comorbidities Total Knee Replacement Cost-Effective, Even With Obesity and Comorbidities
Total knee replacement surgery can be a cost-effective procedure for patients with severe obesity and osteoarthritis, even when they also have comorbidities such as cardiovascular disease or type 2 diabetes, a new study suggests.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - March 23, 2021 Category: Orthopaedics Tags: Orthopaedics News Source Type: news
